Biogen India, located in the capital city of India, New Delhi, takes necessary measures to communicate the problems of Cancer effectively and find breakthrough to help people fight the disease strongly. We, as the company, work hard with high level of dedication and passion to integrate our resources to solve the critical issues of making the Anti-Cancer Medicines, Anti Cancer Tablets, Anti Cancer Injection available at each corner of India. Analytic based decision making helps us better understand the customer requirement and quickly resolve the issues. We engage with manufacturers having a large pool of scientist, and who are dedicated to unite against the deadly Cancer disease.
Key Facts :
Nature of Business
|
Exporter, Trader, Wholesaler, Distributor and Supplier
|
Year of Establishment
|
2009
|
No. of Employees
|
15
|
Warehousing Facility
|
Yes
|
Bankers
|
Nainital Bank
|
Annual Turnover
|
Rs 5 Crores
|
GST No
|
07AENPH8285B1ZC
|
Our Product Portfolio
Biogen India offers following products:
|
-
Pharmaceutical Tablets
-
Flutamide Tablets IP
-
4mg Dexamethasone Tablets
-
Abiraterone Acetate Tablets
-
Sacubitril Or Valsartan Tablets
-
Bethanechol Chloride Tablets USP
-
40mg Megestrol Acetate Tablets IP
-
10mg Tamoxifen Citrate Tablets IP
-
160mg Megestrol Acetate Tablets IP
-
Pharmaceutical Capsules
-
Anti Cancer Medicines
|
|
|
|
|
"Our export market include Kenya, Oman, Dubai, Vietnam, Philippines, Hong Kong, Nigeria, Yemen, Ethiopia."